Envista Holdings Corp Stock Research

Market Summary

USD32.96+0.72

Delayed

2.23%

NVST Alerts

Big fall in earnings (Y/Y)

NVST Stock Price

NVST RSI Chart

NVST Valuation

Market Cap

5.4B

Price/Earnings (Trailing)

25.45

Price/Sales (Trailing)

2.1

EV/EBITDA

14.34

Price/Free Cashflow

49.55

NVST Price/Sales (Trailing)

NVST Profitability

EBT Margin

11.05%

Return on Equity

5.78%

Return on Assets

3.69%

Free Cashflow Yield

2.02%

NVST Fundamentals

NVST Revenue

Revenue (TTM)

2.6B

Revenue Y/Y

-0.67%

Revenue Q/Q

-5.08%

NVST Earnings

Earnings (TTM)

212.0M

Earnings Y/Y

-41.52%

Earnings Q/Q

-40.41%

Price Action

52 Week Range

31.2043.94

(Low)(High)

Last 7 days

-0.9%

Last 30 days

-12.4%

Last 90 days

-17.0%

Trailing 12 Months

-24.9%

NVST Financial Health

Current Ratio

1.15

Debt/Equity

0.35

Debt/Cashflow

0.15

NVST Investor Care

Shares Dilution (1Y)

0.68%

Diluted EPS (TTM)

1.2

Peers (Alternatives to Envista Holdings)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MDT	111.4B	30.8B	-7.64%	-14.31%	27.36	3.62	-3.19%	-17.32%
SYK	110.8B	19.0B	-3.08%	19.15%	46.98	6.01	8.73%	30.37%
ISRG	109.4B	6.4B	2.33%	37.40%	83.37	17.01	8.89%	-20.19%
BDX	71.3B	18.8B	-4.48%	0.69%	44.09	3.79	-1.96%	-15.83%
EW	51.7B	5.5B	-3.13%	-15.68%	34.74	9.4	2.68%	-3.23%
MID-CAP
SWAV	7.2T	557.2M	2.76%	73.14%	82.2K	16.8K	86.42%	730.06%
PEN	12.2B	884.6M	6.58%	119.77%	1.9K	13.82	13.08%	200.12%
GMED	5.9B	1.1B	-1.81%	-16.23%	34.14	5.75	11.20%	53.04%
IRTC	3.2B	430.0M	-20.57%	-26.17%	-30.76	7.49	26.13%	15.73%
TNDM	1.6B	794.7M	-38.00%	-63.12%	-7.85	2.01	7.73%	-3556.34%
SMALL-CAP
SILK	1.2B	150.7M	-27.51%	-13.57%	-21.41	7.78	40.31%	1.80%
AVNS	1.2B	814.3M	1.60%	-13.09%	25.98	1.42	6.96%	121.89%
BLFS	1.0B	163.2M	31.07%	63.84%	-6.86	6.15	17.84%	-885.82%
CSII	839.3M	239.8M	0.70%	0.15%	-22.16	3.5	-4.74%	-31.15%

Financials for Envista Holdings

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	-0.2%	2,565	2,569	2,560	2,536	2,528
Gross Profit	-0.8%	1,463	1,475	1,452	1,443	1,442
S&GA Expenses	0.7%	1,063	1,056	1,074	1,061	1,041
R&D Expenses	0.1%	100	100	100	98.00	99.00
EBITDA	12.4%	354	315	324	436	-
EBITDA Margin	12.0%	0.14*	0.12*	0.13*	0.17*	-
Earnings Before Taxes	-10.6%	254	284	245	252	263
EBT Margin	15.3%	0.11*	0.10*	0.10*	0.11*	-
Interest Expenses	28.1%	49.00	38.00	34.00	35.00	42.00
Net Income	-12.8%	212	243	212	257	300
Net Income Margin	14.2%	0.09*	0.08*	0.10*	0.11*	-
Free Cahsflow	-24.1%	107	141	192	282	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	-0.2%	6,575	6,587	6,412	6,461	6,572
Current Assets	-0.7%	1,414	1,425	1,366	1,388	1,909
Cash Equivalents	-3.6%	585	607	569	523	1,078
Inventory	2.1%	307	301	291	286	280
Net PPE	1.4%	298	294	277	264	264
Goodwill	0.3%	3,506	3,497	3,400	77.00	3,091
Current Liabilities	-7.0%	1,150	1,237	1,258	1,256	1,256
. Short Term Borrowings	0.2%	511	510	579	509	508
Long Term Debt	-0.9%	1,373	1,385	-	-	-
LT Debt, Non Current	0.4%	874	871	852	864	877
Shareholder's Equity	6.3%	4,207	3,958	4,016	4,031	-
Retained Earnings	6.0%	775	731	658	610	563
Additional Paid-In Capital	0.4%	3,713	3,699	3,690	3,678	3,668
Shares Outstanding	0.3%	164	163	163	163	163
Minority Interest	NaN%	-	-	-	-	-

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	-0.2%	182	183	208	250	349
Share Based Compensation	24.6%	38.00	31.00	30.00	30.00	29.00
Cashflow From Investing	-4.1%	-684	-657	-367	-301	273
Cashflow From Financing	-54.4%	6.00	13.00	83.00	5.00	9.00

Risks for NVST

What is the probability of a big loss on NVST?

57.4%

Probability that Envista Holdings stock will be more than 20% underwater in next one year

41.5%

Probability that Envista Holdings stock will be more than 30% underwater in next one year.

26.1%

Probability that Envista Holdings stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NVST drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Envista Holdings was unfortunately bought at previous high price.

Drawdowns

Returns for NVST

Cumulative Returns on NVST

15.2%

3-Year Cumulative Returns

Which funds bought or sold NVST recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-06-01	MACQUARIE GROUP LTD	added	14.44	47,639,000	169,954,000	0.20%
2023-05-26	ProShare Advisors LLC	reduced	-22.41	-24,442	396,904	-%
2023-05-23	Brookfield Corp /ON/	added	158	8,120,500	11,914,800	0.05%
2023-05-23	Front Row Advisors LLC	sold off	-100	-4,000	-	-%
2023-05-23	Toroso Investments, LLC	new	-	584,000	584,000	0.01%
2023-05-22	Raleigh Capital Management Inc.	sold off	-100	-1,447	-	-%
2023-05-22	American Trust	new	-	225,903	225,903	0.02%
2023-05-22	AMERIPRISE FINANCIAL INC	added	0.63	1,575,130	8,678,130	-%
2023-05-18	JPMORGAN CHASE & CO	added	6.62	25,970,000	114,135,000	0.01%
2023-05-18	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-4.09	2,174,000	15,388,000	0.02%

Latest Funds Activity

Are funds buying NVST calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own NVST

No. of Funds

NVST Alerts

Big fall in earnings (Y/Y)

Envista Holdings News

Schedule 13G FIlings of Envista Holdings

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 09, 2023	lazard asset management llc	7.37%	12,032,931	SC 13G
Mar 09, 2023	lazard asset management llc	7.37%	12,032,931	SC 13G
Mar 08, 2023	lazard asset management llc	7.37%	12,032,931	SC 13G
Feb 09, 2023	morgan stanley	8.3%	13,484,631	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	9.81%	15,996,062	SC 13G/A
Feb 08, 2023	massachusetts financial services co /ma/	6.1%	9,878,126	SC 13G
Jan 26, 2023	blackrock inc.	11.4%	18,558,830	SC 13G/A
Jan 20, 2023	blackrock inc.	11.4%	18,558,830	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	0.1%	170,528	SC 13G/A

NVST Fair Value

Show Fair-Value

Recent SEC filings of Envista Holdings

View All Filings

Date Filed	Form Type	Document
May 31, 2023	4	Insider Trading
May 31, 2023	SD	SD
May 26, 2023	8-K	Current Report
May 25, 2023	4	Insider Trading
May 25, 2023	4	Insider Trading
May 25, 2023	4	Insider Trading
May 25, 2023	4	Insider Trading
May 25, 2023	4	Insider Trading
May 25, 2023	4	Insider Trading
May 25, 2023	4	Insider Trading

Latest Insider Trading transactions for NVST

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-25	Conley Eric	sold (taxes)	-21,153	32.95	-642	svp, orthodontics
2023-05-23	Hulit Barbara B.	acquired	-	-	5,425	-
2023-05-23	Carruthers Wendy	acquired	-	-	5,425	-
2023-05-23	Huennekens R Scott	acquired	-	-	7,625	-
2023-05-23	Jain Vivek	acquired	-	-	5,425	-
2023-05-23	GALLAHUE KIERAN	acquired	-	-	5,425	-
2023-05-23	Raskas Daniel	acquired	-	-	5,425	-
2023-05-23	TSINGOS CHRISTINE A	acquired	-	-	5,425	-
2023-02-28	Yu Howard H	sold	-379,606	37.9	-10,016	chief financial officer
2023-02-25	Conley Eric	sold (taxes)	-24,097	38.25	-630	svp, orthodontics

About Envista Holdings

Amir A. Aghdaei

www.envistaco.com

11200

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

NVST Income Statement

2023-03-31

Condensed Consolidated Statements of Operations (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Income Statement [Abstract]
Sales	$ 627.2	$ 631.4
Cost of sales	264.5	257.3
Gross profit	362.7	374.1
Operating expenses:
Selling, general and administrative	266.1	258.2
Research and development	24.5	24.4
Operating profit	72.1	91.5
Nonoperating income (expense):
Other income	0.3	0.3
Interest expense, net	(16.7)	(5.9)
Income before income taxes	55.7	85.9
Income tax expense	11.9	15.5
Income from continuing operations, net of tax	43.8	70.4
Income from discontinued operations, net of tax (Note 3)	0.0	4.5
Net income	$ 43.8	$ 74.9
Earnings per share:
Earnings from continuing operations - basic (in USD per share)	$ 0.27	$ 0.43
Earnings from continuing operations - diluted (in USD per share)	0.25	0.39
Earnings (loss) from discontinued operations - basic (in USD per share)	0	0.03
Earnings (loss) from discontinued operations - diluted (in USD per share)	0	0.03
Earnings - basic (in USD per share)	0.27	0.46
Earnings - diluted (in USD per share)	$ 0.25	$ 0.42
Average common stock and common equivalent shares outstanding:
Basic (in shares)	163.6	162.2
Diluted (in shares)	177.4	179.8

NVST Balance Sheet

2023-03-31

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 585.2	$ 606.9
Trade accounts receivable, less allowance for credit losses of $16.0 and $16.2, respectively	401.8	393.5
Inventories, net	307.2	300.8
Prepaid expenses and other current assets	120.1	123.4
Total current assets	1,414.3	1,424.6
Property, plant and equipment, net	297.6	293.6
Operating lease right-of-use assets	132.9	131.8
Other long-term assets	158.3	153.7
Goodwill	3,506.4	3,496.6
Other intangible assets, net	1,065.5	1,086.7
Total assets	6,575.0	6,587.0
Current liabilities:
Short-term debt	510.8	510.0
Trade accounts payable	186.8	228.3
Accrued expenses and other liabilities	423.6	471.4
Operating lease liabilities	28.4	27.0
Total current liabilities	1,149.6	1,236.7
Operating lease liabilities	121.3	121.4
Other long-term liabilities	151.3	151.3
Long-term debt	873.8	870.7
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at March 31, 2023 and December 31, 2022	0.0	0.0
Common stock - $0.01 par value, 500.0 million shares authorized; 164.4 million shares issued and 163.7 million shares outstanding at March 31, 2023; 163.7 million shares issued and 163.2 million shares outstanding at December 31, 2022	1.6	1.6
Additional paid-in capital	3,712.8	3,699.0
Retained earnings	775.2	731.4
Accumulated other comprehensive loss	(210.6)	(225.1)
Total stockholders’ equity	4,279.0	4,206.9
Total liabilities and stockholders’ equity	$ 6,575.0	$ 6,587.0